Mindy S. Kurzer

Mindy S. Kurzer

Auto-generated profile, based on publicly available information

Mindy S. Kurzer

Department of Food Science and Nutrition, University of Minnesota, St. Paul, MN, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Cancer Letters
Verified
Journal Article
Closed access
HSHamed Samavat
Hamed Samavat
MKMindy S. Kurzer
Mindy S. Kurzer

1 June 2000 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
BMBarbara E Merz-Demlow
Barbara E Merz-Demlow
ADAlison M Duncan
Alison M Duncan
KWKerry E Wangen
Kerry E Wangen
XXXia Xu
Xia Xu
TCTimothy P Carr
Timothy P Carr
MKMindy S Kurzer
Mindy S Kurzer
Background: Soy consumption is known to reduce plasma total cholesterol and LDL cholesterol in hypercholesterolemic subjects, but the responsible soy components and the effects in normocholesterolemic subjects remain unclear. Objective: The effects of soy isoflavone consumption on plasma total cholesterol, HDL-cholesterol, LDL-cholesterol, triacylglycerol, apolipoprotein A-I, apolipoprotein B, and lipoprotein(a) concentrations and on LDL peak particle diameter were examined in normocholesterolemic, premenopausal women. Design: Thirteen healthy, normocholesterolemic, free-living, premenopausal female volunteers took part in this randomized, crossover-controlled trial. Each subject acted as her own control. Three soy isoflavone intakes (control: 10.0 ± 1.1; low: 64.7 ± 9.4; and high: 128.7 ± 15.7 mg/d), provided as soy protein isolate, were consumed for 3 menstrual cycles each. Total cholesterol, HDL cholesterol, LDL cholesterol, and triacylglycerol were measured over the menstrual cycle. Apolipoprotein A-I, apolipoprotein B, lipoprotein(a), and LDL peak particle diameter were evaluated in the midluteal phase. Results: Total cholesterol, HDL-cholesterol, and LDL-cholesterol concentrations changed significantly across menstrual cycle phases (P < 0.005). During specific phases of the cycle, the high-isoflavone diet lowered LDL cholesterol by 7.6–10.0% (P < 0.05), the ratio of total cholesterol to HDL cholesterol by 10.2% (P < 0.005), and the ratio of LDL to HDL cholesterol by 13.8% (P < 0.002). Conclusions: Isoflavones significantly improved the lipid profile across the menstrual cycle in normocholesterolemic, premenopausal women. Although of small magnitude, these effects could contribute to a lower risk of developing coronary heart disease in healthy people who consume soy over many years.

1 December 2016 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
HSHamed Samavat
Hamed Samavat
ANApril R Newman
April R Newman
RWRenwei Wang
Renwei Wang
JYJian-Min Yuan
Jian-Min Yuan
AWAnna H Wu
Anna H Wu
MKMindy S Kurzer
Mindy S Kurzer
Background: Green tea has been suggested to improve cardiovascular disease risk factors, including circulating lipid variables. However, current evide

1 March 2002 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
MKMindy S. Kurzer
Mindy S. Kurzer
Over the past few years, there has been increasing interest in the possible hormonal effects of soy and soy isoflavone consumption in both women and men. Soy consumption has been suggested to exert potentially cancer-preventive effects in premenopausal women, such as increased menstrual cycle length and sex hormone-binding globulin levels and decreased estrogen levels. There has been some concern that consumption of phytoestrogens might exert adverse effects on men's fertility, such as lowered testosterone levels and semen quality. The studies in women have provided modest support for beneficial effects. One cross-sectional study showed serum estrogens to be inversely associated with soy intake. Seven soy intervention studies controlled for phase of menstrual cycle. These studies provided 32–200 mg/d of isoflavones and generally showed decreased midcycle plasma gonadotropins and trends toward increased menstrual cycle length and decreased blood concentrations of estradiol, progesterone and sex hormone-binding globulin. A few studies also showed decreased urinary estrogens and increased ratios of urinary 2-(OH) to 16α-(OH) and 2-(OH) to 4-(OH) estrogens. Soy and isoflavone consumption does not seem to affect the endometrium in premenopausal women, although there have been weak estrogenic effects reported in the breast. Thus, studies in women have mostly been consistent with beneficial effects, although the magnitude of the effects is quite small and of uncertain significance. Only three intervention studies reported hormonal effects of soy isoflavones in men. These recent studies in men consuming soyfoods or supplements containing 40–70 mg/d of soy isoflavones showed few effects on plasma hormones or semen quality. These data do not support concerns about effects on reproductive hormones and semen quality.

1 December 2017 in Cancer Prevention Research
Verified
Journal Article
Closed access
PDF file
HSHamed Samavat
Hamed Samavat
GUGiske Ursin
Giske Ursin
TETim H. Emory
Tim H. Emory
ELEunjung Lee
Eunjung Lee
RWRenwei Wang
Renwei Wang
MKMindy S. Kurzer
Mindy S. Kurzer
Epidemiologic and animal studies suggest a protective role of green tea against breast cancer. However, the underlying mechanism is not understood. We conducted a randomized, double-blinded, placebo-controlled phase II clinical trial to investigate whether supplementation with green tea extract (GTE) modifies mammographic density (MD), as a potential mechanism, involving 1,075 healthy postmenopausal women. Women assigned to the treatment arm consumed daily 4 decaffeinated GTE capsules containing 1,315 mg total catechins, including 843 mg epigallocatechin-3-gallate (EGCG) for 12 months. A computer-assisted method (Madena) was used to assess MD in digital mammograms at baseline and month 12 time points in 932 completers (462 in GTE and 470 in placebo). GTE supplementation for 12 months did not significantly change percent MD (PMD) or absolute MD in all women. In younger women (50–55 years), GTE supplementation significantly reduced PMD by 4.40% as compared with the placebo with a 1.02% PMD increase from pre- to postintervention (P = 0.05), but had no effect in older women (Pinteraction = 0.07). GTE supplementation did not induce MD change in other subgroups of women stratified by catechol-O-methyltransferase genotype or level of body mass index. In conclusion, 1-year supplementation with a high dose of EGCG did not have a significant effect on MD measures in all women, but reduced PMD in younger women, an age-dependent effect similar to those of tamoxifen. Further investigation of the potential chemopreventive effect of green tea intake on breast cancer risk in younger women is warranted. Cancer Prev Res; 10(12); 710–8. ©2017 AACR.

1 January 2016 in The Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
ADAllison M Dostal
Allison M Dostal
HSHamed Samavat
Hamed Samavat
LELuis Espejo
Luis Espejo
AAAndrea Y Arikawa
Andrea Y Arikawa
NSNicole R Stendell-Hollis
Nicole R Stendell-Hollis
MKMindy S Kurzer
Mindy S Kurzer
Background: Green tea consumption has been associated with favorable changes in body weight and obesity-related hormones, although it is not known whe